Displaying 1 - 9 of 9

vaccine

Flu vaccine to be extended to everyone aged 50 to 64 years

From Wednesday 15 January 2025, the seasonal flu vaccination will also be available for everyone aged 50 to 64 years of age. The Public Health Agency (PHA) is urging everyone who is eligible for vaccination to take up the offer when invited, particularly those at greatest risk as flu continues to circulate at high levels. Those who are at greatest risk and are currently eligible to get the flu vaccine are advised to make arrangements now to get it ahead of an anticipated increase in demand when availability is expanded on 15 January. Dr Joanne McClean, Director of Public Health at the Public

Open letter from the Public Health Agency to people ‘at risk’ regarding the winter vaccines

The Public Health Agency (PHA) is encouraging people who fall into an ‘at risk’ group to take up the offer of the winter vaccinations. All individuals in clinical risk groups who are aged from six months to 65 years, as well as those aged 65 years and older, are advised to receive the seasonal flu and COVID-19 vaccines. If you are ‘at risk’, either due to older age, a health condition, medical treatment or pregnancy, you are at increased chance of becoming seriously unwell if you contract flu or COVID-19. These viruses tend to circulate at higher levels during the winter months. Vaccines are

COVID-19 vaccination - What to expect and translations

This leaflet contains information for people who have just had a COVID-19 vaccination, either first dose, second or booster dose. It contains information on the vaccine, potential side effects and what to do next. 

Changes to the infant pneumococcal conjugate vaccine schedule - Information for healthcare practitioners

This factsheet describes the infant pneumococcal conjugate vaccine schedule. Infants will be offered a dose of PCV vaccine at dose at 16 weeks old and again just after their first birthday. 

This factsheet describes the infant pneumococcal conjugate vaccine schedule. Infants will be offered a dose of PCV just after their first birthday. 

 

Annual Immunisation and Vaccine Preventable Diseases Report for Northern Ireland 2015-16

This report aims to provide an overview of both adult and childhood immunisation programmes in Northern Ireland for 2015-16. It also provides information on vaccine preventable epidemiology in Northern Ireland in 2015.

Syphilis: what your positive screening result means (English and 11 translations)

This leaflet is for pregnant women who have been diagnosed with syphilis. It provides information on the care pathway for these women, including referral to GUM, treatment and long-term protection for the baby.

 

This leaflet is for pregnant women who have been diagnosed with syphilis. It provides information on the care pathway for these women, including referral to sexual health (GUM) clinics, treatment and long-term protection for the baby.

Printing instructions are provided in a PDF below.

Hepatitis C - Clinician results factsheet

This factsheet provides information in the form of FAQs in relation to hepatitis C: the condition, risks, testing, treatment and management.

Hepatitis B - Quick reference guide for primary care

This factsheet provides information in the form of FAQs in relation to hepatitis B: the condition, prevalence, risks, testing, management, vaccination and treatment.

Hepatitis B: what your positive screening result means (English and translations)

This leaflet is for pregnant women who have been diagnosed with hepatitis B. It provides information on the care pathway for these women.

This leaflet is for pregnant women who have been diagnosed with hepatitis B. It provides information on the care pathway for these women, including referral to a liver specialist, the vaccination course for the newborn child, and long-term protection from the infection. It has been updated to include new advice on immunisation of babies from 1 August 2017.


PDFs of the leaflet are also available in 15 languages.

Printing instructions are provided in a PDF below.

Subscribe to vaccine